A detailed history of Allianz Asset Management Gmb H transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 6,500 shares of REGN stock, worth $6.83 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,500
Previous 152,311 95.73%
Holding current value
$6.83 Million
Previous $134 Million 95.32%
% of portfolio
0.01%
Previous 0.25%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$902.69 - $993.35 $25.6 Million - $28.2 Million
-28,361 Reduced 18.62%
123,950 $119 Million
Q4 2023

Feb 12, 2024

SELL
$775.18 - $881.7 $4.87 Million - $5.54 Million
-6,282 Reduced 3.96%
152,311 $134 Million
Q3 2023

Nov 13, 2023

BUY
$692.45 - $844.37 $1.66 Million - $2.03 Million
2,400 Added 1.54%
158,593 $131 Million
Q2 2023

Aug 11, 2023

SELL
$700.03 - $830.35 $54.8 Million - $65 Million
-78,242 Reduced 33.37%
156,193 $112 Million
Q1 2023

May 11, 2023

SELL
$680.49 - $826.97 $35,385 - $43,002
-52 Reduced 0.02%
234,435 $193 Million
Q4 2022

Feb 13, 2023

SELL
$705.89 - $766.39 $12.9 Million - $14 Million
-18,241 Reduced 7.22%
234,487 $169 Million
Q3 2022

Nov 08, 2022

SELL
$573.97 - $724.32 $12.7 Million - $16 Million
-22,136 Reduced 8.05%
252,728 $174 Million
Q2 2022

Aug 12, 2022

SELL
$548.35 - $738.84 $8.09 Million - $10.9 Million
-14,757 Reduced 5.1%
274,864 $162 Million
Q1 2022

May 13, 2022

BUY
$595.12 - $698.43 $18.3 Million - $21.4 Million
30,707 Added 11.86%
289,621 $202 Million
Q4 2021

Feb 11, 2022

BUY
$543.48 - $670.97 $6.82 Million - $8.42 Million
12,549 Added 5.09%
258,914 $164 Million
Q3 2021

Nov 10, 2021

BUY
$574.03 - $680.96 $482,185 - $572,006
840 Added 0.34%
246,365 $149 Million
Q2 2021

Aug 16, 2021

BUY
$472.8 - $558.54 $50.1 Million - $59.1 Million
105,869 Added 75.81%
245,525 $137 Million
Q1 2021

May 13, 2021

BUY
$446.73 - $548.2 $12.6 Million - $15.4 Million
28,176 Added 25.27%
139,656 $66.1 Million
Q4 2020

Feb 16, 2021

SELL
$478.3 - $607.98 $3.26 Million - $4.14 Million
-6,811 Reduced 5.76%
111,480 $53.9 Million
Q3 2020

Nov 13, 2020

SELL
$544.75 - $658.21 $7.47 Million - $9.02 Million
-13,709 Reduced 10.39%
118,291 $66.2 Million
Q2 2020

Aug 14, 2020

SELL
$493.32 - $643.92 $9.2 Million - $12 Million
-18,648 Reduced 12.38%
132,000 $82.3 Million
Q1 2020

May 14, 2020

SELL
$336.18 - $494.43 $416,527 - $612,598
-1,239 Reduced 0.82%
150,648 $73.6 Million
Q4 2019

Feb 13, 2020

BUY
$274.13 - $376.51 $9.14 Million - $12.6 Million
33,344 Added 28.13%
151,887 $57 Million
Q3 2019

Nov 13, 2019

BUY
$273.46 - $318.39 $2.16 Million - $2.52 Million
7,913 Added 7.15%
118,543 $32.9 Million
Q2 2019

Aug 08, 2019

SELL
$299.6 - $414.82 $1.76 Million - $2.43 Million
-5,858 Reduced 5.03%
110,630 $34.6 Million
Q1 2019

May 13, 2019

BUY
$372.08 - $439.57 $19.6 Million - $23.2 Million
52,759 Added 82.79%
116,488 $47.8 Million
Q4 2018

Feb 14, 2019

BUY
$335.82 - $403.04 $6.88 Million - $8.25 Million
20,478 Added 47.35%
63,729 $23.7 Million
Q3 2018

Nov 13, 2018

SELL
$351.14 - $408.51 $6.71 Million - $7.8 Million
-19,106 Reduced 30.64%
43,251 $17.5 Million
Q2 2018

Aug 13, 2018

SELL
$284.6 - $344.99 $4.63 Million - $5.61 Million
-16,252 Reduced 20.67%
62,357 $21.5 Million
Q1 2018

May 14, 2018

SELL
$315.82 - $393.78 $39.9 Million - $49.7 Million
-126,293 Reduced 61.64%
78,609 $27.1 Million
Q4 2017

Feb 13, 2018

BUY
$358.63 - $469.95 $19.1 Million - $25 Million
53,292 Added 35.15%
204,902 $77 Million
Q3 2017

Nov 13, 2017

BUY
$431.38 - $504.0 $5.72 Million - $6.69 Million
13,265 Added 9.59%
151,610 $67.8 Million
Q2 2017

Aug 14, 2017

SELL
N/A
-26,901 Reduced 16.28%
138,345 $69.3 Million
Q1 2017

Apr 17, 2019

BUY
N/A
28,603 Added 20.93%
165,246 $64 Million
Q4 2016

Apr 17, 2019

BUY
N/A
19,732 Added 16.88%
136,643 $50.2 Million
Q3 2016

Apr 17, 2019

BUY
N/A
116,911
116,911 $47.3 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $113B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.